EyeGate Soars After It Appoints A New CEO And Plans For An Acquisition

EyeGate Pharmaceuticals (EYEG) – Get Report skyrocketed Tuesday after the biotech named Brian Strem as president and CEO, while announcing it had signed a non-binding letter of intent to acquire specialty pharmaceutical company Bayon Therapeutics.

!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()
{n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
;if(!f._fbq)f._fbq=n;
n.push=n;n.loaded=!0;n.version=’2.0′;n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
document,’script’,’https://connect.facebook.net/en_US/fbevents.js’);
(function(){
fbq(‘init’, ‘135067773744716’);
fbq(‘track’, ‘PageView’);
var contentId = ‘ci02892c32f00125a3’;
if (contentId !== ”) {
fbq(‘track’, ‘ViewContent’, {content_ids: [contentId], content_type: ‘product’});
}
})(); .